GGrantIndex
Sort

53,477 grants matching addiction

Combination Therapies to Defeat Melanoma Resistance

$2,556,789
Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA

Combination Therapies to Defeat Melanoma Resistance

$2,556,789
Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA

Spinal Manipulation and Patient Self-Management to Prevent Back Pain Chronicity

$2,556,035
Gert Bronfort · University Of Minnesota · UH3 · FY2021 · AT

Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs

$2,553,038
Matthew W Kalnik · Antidote Therapeutics, Inc. · R01 · FY2014 · DA

Insula-BNST Circuit Regulation of AUD

$2,552,568
Samuel Centanni · Wake Forest University Health Sciences · R01 · FY2025 · AA

Integrated GWAS of complex behavioral and gene expression traits in outbred rats

$2,551,355
Abraham A Palmer · University Of California, San Diego · P50 · FY2017 · DA

Psychotherapy Development Research Center

$2,549,855
Kathleen M Carroll · Yale University · P50 · FY2016 · DA

Psychotherapy Development Research Center

$2,547,438
Kathleen M Carroll · Yale University · P50 · FY2014 · DA

HEAL Research on Interventions for Stability and Engagement (RISE) Network Coordination Center

$2,546,287
Jessica Duncan Cance · Research Triangle Institute · U24 · FY2025 · DA

Frontal Striatal Systems and Dopamine in Normal and Pathological Behavior

$2,543,913
Bruno Averbeck · National Institute Of Mental Health · ZIA · FY2025 · MH

STRATEGIES FOR REDUCING NICOTINE CONTENT IN CIGARETTES

$2,542,748
Dorothy K Hatsukami · University Of Pittsburgh At Pittsburgh · U54 · FY2015 · DA

Novel Econometric Research Designs (NERD) to Help End Addiction Long-term

$2,542,500
Ali Jalali · Weill Medical Coll Of Cornell Univ · DP2 · FY2024 · DA

Linking genes to higher brain function by way of cellular electrophysiology

$2,542,500
Gaby Maimon · Rockefeller University · DP2 · FY2012 · DA

A novel framework for the functional dissection of motor systems

$2,542,500
Nicolas Xavier Tritsch · New York University School Of Medicine · DP2 · FY2017 · NS

Center for Genetic Studies of Drug Abuse in Outbred Rats

$2,541,203
Abraham A Palmer · University Of California, San Diego · P50 · FY2023 · DA

Targeted Therapies for Glioma

$2,539,918
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2024 · CA

Psychotherapy Development Research Center

$2,537,791
Kathleen M Carroll · Yale University · P50 · FY2017 · DA

Evaluating New Nicotine Standards for Cigarettes

$2,537,775
Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2011 · DA

Basic and Translational Research Center for Reducing Health Disparities

$2,536,906
Jesus Alexander Angulo · Hunter College · G12 · FY2013 · MD

Psychotherapy Development Research Center

$2,535,538
Kathleen M Carroll · Yale University · P50 · FY2015 · DA

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,535,440
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2022 · DA

NIDA Clinical Trials Network: Greater New York Node

$2,533,075
John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA

Disrupted Adenovirus Serotype 5-based Anti-cocaine Vaccine

$2,528,781
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2013 · DA

CASCADE: A North Carolina cohort to address the cascading effects of the HIV and substance use syndemic

$2,528,513
Christina S Meade · Wake Forest University Health Sciences · U01 · FY2025 · DA

Project-002

$2,526,880
John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA